Literature DB >> 1282104

Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study.

N Bel1, F Artigas.   

Abstract

The effects of systemic administration of fluvoxamine on extracellular serotonin (5-hydroxytryptamine, 5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) concentrations in the frontal cortex and raphe nuclei of freely moving rats were examined. Fluvoxamine significantly increased extracellular 5-HT concentrations in both regions at the two doses used (1 and 10 mg/kg i.p.). However, the increase in the raphe nuclei was several-fold that in the frontal cortex. Dialysate 5-HIAA concentrations decreased after treatment with fluvoxamine. These results confirm that 5-HT uptake inhibitors preferentially increase extracellular concentrations of 5-HT in the vicinity of cell bodies and dendrites of serotonergic neurones.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1282104     DOI: 10.1016/0014-2999(92)90292-c

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  54 in total

1.  Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.

Authors:  M Hajós; E Hajós-Korcsok; T Sharp
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  MDMA induced dopamine release in vivo: role of endogenous serotonin.

Authors:  S Koch; M P Galloway
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Antidepressant-like effects of SR 57227A, a 5-HT3 receptor agonist, in rodents.

Authors:  M Poncelet; A Perio; J Simiand; G Gout; P Soubrie; G Le Fur
Journal:  J Neural Transm Gen Sect       Date:  1995

4.  Light therapy and serotonin transporter binding in the anterior cingulate and prefrontal cortex.

Authors:  S J Harrison; A E Tyrer; R D Levitan; X Xu; S Houle; A A Wilson; J N Nobrega; P M Rusjan; J H Meyer
Journal:  Acta Psychiatr Scand       Date:  2015-04-17       Impact factor: 6.392

5.  Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors.

Authors:  L J Dreshfield; D T Wong; K W Perry; E A Engleman
Journal:  Neurochem Res       Date:  1996-05       Impact factor: 3.996

Review 6.  Spotlight on fluvoxamine in anxiety disorders in children and adolescents.

Authors:  Susan M Cheer; David P Figgitt
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

7.  Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat.

Authors:  Marian Geldof; Jan Freijer; Ludy van Beijsterveldt; Meindert Danhof
Journal:  Pharm Res       Date:  2007-08-21       Impact factor: 4.200

8.  Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat.

Authors:  P Celada; F Artigas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

9.  Brain monoamines and antidepressant-like responses in MRL/MpJ versus C57BL/6J mice.

Authors:  Darrick T Balu; Jill R Turner; Bethany R Brookshire; Tiffany E Hill-Smith; Julie A Blendy; Irwin Lucki
Journal:  Neuropharmacology       Date:  2012-12-06       Impact factor: 5.250

10.  Effects of 5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus on the antidepressant-like action of tramadol in the unpredictable chronic mild stress in mice.

Authors:  Ipek Yalcin; Stéphanie Coubard; Sylvie Bodard; Sylvie Chalon; Catherine Belzung
Journal:  Psychopharmacology (Berl)       Date:  2008-06-26       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.